Anxiety
Conditions
Interventions
The study is characterized by being a longitudinal clinical study in which quantitative data will be evaluated, such as the effects of the intervention with medical cannabis on the dependent variables
and who are in a situation of mental and physical suffering. In this way, in the design of this research, the participant will be in control of himself.
It is also important to inform that treatment w
D26.528
Sponsors
Universidade Federal de São Paulo
Universidade Federal de São Paulo
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: People over 18 years of age; patients who will start treatment with medical cannabis; who are newly linked to cannabis associations; who have been diagnosed with cancer; and who are undergoing cancer treatment.
Exclusion criteria
Exclusion criteria: Interdicted and/or curated patients; under 18 years of age; using antidepressants or anxiolytics, and people undergoing palliative treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find effects of improvement in the quality of life of cancer patients undergoing treatment with medical cannabis through the WHOQOL-bref quality of life assessment instrument, based on the verification of a variation of at least 5% in the pre, post-intervention and follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to find a reduction in anxiety and depression symptoms among cancer patients using medical cannabis through the application of the depression, anxiety and stress scale (DASS-21), based on the observation of a variation of at least 5% in the pre, post intervention and follow-up measurements. | — |
Countries
Brazil
Contacts
Public ContactAdriana Tucci
Universidade Federal de São Paulo
Outcome results
None listed